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of 60 were followed up to August 1996 to evaluate the impact of estrogen
therapy on target lesion revaacularization. Eatrogen therapy was continued
throughout the follow-up (FU) period. Between the two groups, there was
no significant difference in age, incidence of coronaty risk factors (hyperten-
sion, diabetes mellitus, hypercholesterolemia and smoking), LVdysfunction,
incidence of multiveasel disease, lesion morphology, vessel site stented and
number of atents per vessel or types of stent (Cook vs. JJIS). The long-term
outcomes are as follows:
Estrogen (n= 62) No Estrogen (n =55) p Value
FU davs 556 & 2S4 516 + 267 ns
i+ci;;intengina 2 (3”/0) s (15%) 0.04
Revascularization 12 (19%) 24 (44°/0) 0.0065
(PTCA and CABG) Death O 1 ne
FU angiograms were obtained only in 26 out of 62 in estrogen treatment
group with angiographic restenosis of 50% and 26 out of 55 in no estrogen
treatment group with restenosis of 85%.
Conclusions: Estrogen replacement therapy in post menopausal women
reduces angina and target lesion revascularization after intrecoronary atent-
ing. Further substantiation by large randomized studies is needed.
m1059144 OptimalCoronaryStentinginDiabetice:A ViabiePercutanaouaAlternativeto CardiacSurgery
F.V.Tilli, D. Aliabadi, T. Bowera, ‘M.M. Shoukfeh, M. Spybrook, R.D. Sefian.
William Beaumont Hospital, Royal Oak, Ml, USA
Diabetics have significantly higher ratas of target vessel revascularization
(TVR) compared with non-diabetics following percutaneous intervention.
Earlier studies have reported TVR rates > 50% in diabetics despite use
of intracoronafy atents. Recent randomized studies have sugge6ted that
diabetics with multi-vassel coronaIy disease fare better with surgical revas-
txrlarization. In the era of optimal coronary stenting, however, it may be
possible to minimize the need for TVR in diabetics, thareby making percuta-
neous revascularization more attractive. We assessed 9 month TVR in 316
consecutive patients stented between 11/94and 6/95, 81 of whom were dia-
betic. All stents were implanted using routine high pressure post-dilatations.
Diabetes was a strong predictor of TVR, necessary in 24/61 (W%) diabetics
vs. 36/234 (15%) non-diabetics, (p= 0.008). Recurrentangina prompted TVR
in 57/60 (95%) of cases.
Conclusions: Diabetes increases the likelihood of need for TVR two-fold
compared with non-diabetics. Despite this, use of optimal stenting technique
can result in mora acceptable restenosis rates compared with early stent
experience in diabetics. Whether percutaneous revascularization employing
optimal stenting technique compares favorably with surgery for diabetics with
multi-vessel coronary disease requires further investigation.
m1059145 NoExcaaaMotteiityAfterCoronaryAngiopiaetyin Diabetic Patienta with Multiveaael Dieeaee
after Prior Bypaaa Surgery
E. Frantz, P. Pfautsch, S. Mr%ldel,E. Fleck. Cardiology, Virchow C/inic,
Humboldt University and German Hear?Institute, Berfin, Germany
Recently an alert has been issued, that patients (pts) on drug treatment for
diabetes mellitus with multivessel CAD should not be treated by PTCA be-
cause of increased mortality compared to corona~ bypass surgery (CABG).
We investigated, whether this also is relevant for pts with recurrent ischemia
after prior CABG surgery.
n = 489 pts. (46.6 + 44 months after CABG) were treated by PTCA
(n = 438) or”Re-CABG (n = 51). Diabetes was present in 99 pts (20.2%),
(18.9% in PTCA; 31.4% in Re-CABG-groupa, resp.). During follow-upof 32.0
+ 25.2 months, 44 pts. died (30 in PTCA-group, 14 in Re-CABG-group).
3-yr-Mortality was 37.4% in diabetic pts. in Re-CABG-group, 25.7% in non-
diabetics in Re-CABG-group, 7.2% in diabetics in PTCA-group and 7.4%
in non-diabetics in PTCA-group. Cox hazard analysis identified diabetes as
risk factor for death with x 1.43 rel. risk (p < 0.007) in all patients, Survival
Cuwes:
Conclusions: In this series, redo bypass surgery resulted in higher death
rates than angioplasty for diabetic patients as well as for non-diabetic pa-
tients. Nevertheless, irrespective of treatment ragimen, diabetes is a risk
factor for fatal adverse cardiac events at follow-up.
11059-1461 CoronaryStentingintheDiabeticPatients:~ariy
and Follow-up Reeulta
H. Yokoi, H. Noaake, T. Kimura, T. Tamura, Y. Nakagawa, N. Hamasaki,
M. Nobuyoshi. Kokura Memorial Hospital, Kitakyushu, Japap
Balloon PTCA in diabetic (D) patients (pts) has been associated with iess
favorable outcomes due to their increased incidence of restenosis and pro-
gression of disease. To assess whether Palmez-Schatz (PS) stent iaa useful
alternative to bailoon PTCA in D, immediate and follow-up (FU) results were
analyzed in consecutive 931 pts received PS implantation and compared D
pts with none-diabetic (ND) pts. Clinical success was defined as < 50% resid-
ual stenosis without death, CABG, Q-wave Ml. FU quantitative angiography
was obtained from 819 pts (66Y0)after 6 months or earlier when indicated
by symptoms. Clinical FU data was obtained after 12 months. Event-free
survival was definsd as free from death, Ml, CABG, target and new lesion
PTCA at FLL
D (N = 2s3) ND (N = 66s)
.,
Multi Vsseel*/Poor LV* (OA) 69/18 57/12
Calcification (%VLL (mm) 24/12,5 1S/11.8
Reference diam’eter(mmj 3,24 + 0.65 3.23 + 0.84
Pre MLD (mm) 0.76 + 0.46 0.76 + 0.47
Post MLD (mm) 2.66 + 0.50 2.88 + 0.49
Clinical Success (%) 97 95
Death/Ml/CABG (%) 0.4/1 .1/0.4 2.3/1 .5/1.2
Thromboeia (%) 0.s 1,s
Bleeding complication (%) 4.6 4.9
FU MLD* (mm) 1.93 * 0.91 2.06 l 0.82
Binaiy restenosis*~LR (%) 29/19 22/15
Event Free Suivivsl (%) 32 27
*p <0.05, MLD = minimal lumen diameter, LL = iesion length
Conclusion: 1) PS stent implantation can be performed in D pts with the
acceptable complications despite unfavorable clinical environment. 2) But
restenosis following stenting in D is significantly higher because of greater
late loss, probably reflecting more aggressive intimal hyperplasia.
I1059-147I Corona~stentingDUringEmergency
Angioplasty in High-Risk Myocardial Infarction:
Data From a Multicenter Registry
G.Steffenino 1,S. Chierchia, A. Fontaneili, L. Niccoli, S. Repetto, G. Risice
for the RAI Regisby Investigators. ‘ Di!z of Cardiology Ospeda/e S. Croce,
Cuneoj /fa/y
Use of coronary atents (CS) during amergency angioplasty (EM-PTCA) in
acute myocardial infarction (AMI) is controversial. The l-year RAi registry
was started in November ’95 to monitor the pariormance, in-hospital and
6-month outcome, and resource use of EM-PTCA in high-risk AMI (large
anterior or inferior, recurrent, post CABG, with pump failure), in 6 Centers
where EM-PTCA is currently performed. In the Ist semester PTCA was
attempted in 135 pts, with use of CS in 68 pts (50%): 6 women, age 56 +
10 (29-79 y). Five pts had failed iv Iysis, and 9 (13%) were in shock. CS
were implanted immediately after PTCA in all cases: the indication was a
threatening dissection or unsatisfactory balioon result in 55 pts, and elective
in 13 (19%). Vessel distribution was as follows: 36 LAD (53%), 23 RCA, 4
Cx/OM, and 5 SVG. IABP was used in 15 pts (22%) Immediate success was
achieved in 67 pts (99%), with balloons of 3.4 + 0.3 mm at 15 + 2 atm.
Multipie CS were uaed in 14 pts. (21%). Final flow was TIMI 3 and 2 in 65
and 3 ceees, respectively,and residual StenOSiSwas 12 + 4%.; pain was
absent in 60 pts, with a normal ST segment in 32 (47%). During hospitai stay
(10 + 4 d; 5-24) 6 pts (9%) had subacute CS occlusion (with redo PTCA in
3, and CABG in 2), 2 pts had vascular repair, and 5 pts (7Yo)died, due to
persistent shock in 3. Medication at discharge (61 pts) inciuded ticlopidine
alone in 40 pta (66Yo),aspirin alone in 7 pts, both in 8 pts, and antimagulants
in 6 pts. Follow-up angiographic results in this cohort will be available in Nov.
’96. /n conclusion.’CS may increase the immediate success of EM-PTCA in
the compromised pt with high-risk AMI, with few complications.
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1059-148 Stenting in Acute Myocardiai infarction (STAMI):
Bailout, Conditional and Planned Stente
K.H. Benzuly, W.W. O’Neill, V. Gangadharan, S.L. Almany, D. Maraalese,
S.C. Ajluni, F.V.Tilli, A.D. Berman, D. Mason, R.D. Safian. William
Beaumont Hospital, Royal Oak, Ml, USA
Patients with acute myooardial infardion (AMI) are at high risk for coronary
stenting, but the optimal strategy for stenting in these patients is unclear.
Between May 1993and June 1996, 97patients with AMl underwent Ooronaw
stenting (success 94%), including bailout stenting (BS) for abrupt closure (n
= 31), conditional stenting (CS) for suboptimal PTCA (n = 30), and planned
primary stenting (PS, n = 30). The ES and CS groups included patients with
thrombolytie failure (BS: 19%, CS: 16%) and shc$k (BS: 14%, CS: 16%).
Transfusion was required in 27 patients (BS: 44%, CS: 26%, PS: 10%).
In-HospitalEvents(%) BS Cs Ps
Dasth 9.7 6.5 3.3
StentThrombosis 6.4 3.2 0
CABG 13 3,2 3.3
Major Complication 29 13 3.3*
*p< 0.05
Conckwiom 1.) Patients with failed primary PTCA are at high risk for
ischemic complications, despite successful bailout stenting. 2.) Conditional
stenting in AMI is associated with a lower incidence of in-hospital ischemic
events compared to bailout stenting. 3.) Planned stenting is safe in a select
group of patienta with AMI, and is associated with a low risk of complications.
11059-163\suPeri0ritY0fCor0narYstentin9ComParedto
Balloon Angioplaety in Acute Myocardiai
infarction
M. Ganim, P.Wong, R. Grover, A. Chuang, A. Pathan, K. Fujise,
R.L. Kirkeeide, H.V. Anderson, G.W. Schroth, R.W. Smalling. University of
TexasMedical School, Herrnann Hospital, Houston, TX, USA
Acute myocardial infarction (AMI) has been considered a relative contraindi-
cation to coronary stenting. The objective of thia study was to compare the
in-hospital outcome of patients undergoing coronary stenting veraus PTCA
in the setting of AMI. We analyzed 95 eonsacutive patients from August ’94
to July ’96 who presented with AMI and underwent PTCA (n =40, age 55 +
14) or coronary stenting (n = 55, age 57 + 10) within 7 days of AMI. PTCA
indications: ptimaty 27Y0,rescue 23%, eardiogenic shock 15% and elective
35%. Stent indications: primary 13%, rescue 24%, cardioganic ahoek 7%,
suboptimal results 18°Aand elective 36%. The peak CK-MB index waa 7.5
+ 4.7 and the ejection fraction was 0.50+ 0.13 for the PTCA group and 7.7
+ 3.6 and 0.54 + 0.15 respectively for the stent group. The pre-procedure %
stenosis by on-line QCA was 93+ 11for the PTCA group and W + 11for the
stent group (includes total occlusions). Subacute closure rate was 2.5Y0with
PTCAVS. 3.6% in the atent group. The overall mortality rate was 15% for the
PTCA group and 3.6% for the stent group (p= 0.056) with cardiac mortality
rate being 12.5Y0and O%in the respective groups (p= 0.011).There was an
increase riak of bleeding complication in the stent group (12.7% vs. 7.5%,
p = 0.32). This ‘MM posaibly due to the use of post procedure heparin and
eoumadin in many early stent patients. Conclusion: Stenting in the setting of
AMI maybe more efficacious than PTCAand isnotaesoeiated with excessive
thrombotic complications.
{1059-1641~;:::;::::~~:;~:g inp.tienta~it~A~ute
S.-W. Park, S.-J. Park, M.-K. Hong, S.-S. Cheong, J.-J. Kim, C.-W. Lee,
J.-K. Song, K.-J. Choi, Y.-H. Kim. Univarsifyof ULsan,Asan Medical CerrteL
Saoul, Koras
Thepercutanaous transluminal balloon angioplasty (PTCA)on infarct-related
artery (IRA) isaaaociatad with high incidence of restenosis. However,stenting
was empirically thought to be contra-indicated for acute myocardial infarction
(Ml) bacauae of the propensity forthromboaia. Therefore, the purpose of this
atudy was to investigate the effect of stent implantation on restenosis of IRA
in acute Ml. From January 1994 to December 1995, 97 patients (pts) (45
pts: stent, 52 pta: PTCA) underwent intraeoronaty stenting or P’TCAon IRA
at 7-10 days after acute Ml onset. Follow-up angiography was performed
6 months later after intervention in all pts. Thallium-201 myocardial scan
revealed partially reversible defects corresponding to vascular territory of
IRA in all pts. The coronary stents were Palmaz-Schatz stent in 35 pts and
Cordia stent in 10 pts.
Slent (n = 45) PTCA(n. 52)
Age (years) 54.1 53.9
Ejectionfraction(%) 56.7* 6.2 54.S* 10.2
Pre-MLD(mm) 0.9* 0.4 0.8+ 0.5
Post-MLD(mm] 3.7* 0.5 2.9&0.3
Follow-upMLD(mm) 2.7+ 0.9 1.4+ 1.0
Referencearterysize(mm) 3.5* 0.4 3.4* 0.4
AngiographicRestenosis* 6 (13) 27 (52)
“p <0.05
Cmrc/usion: The intraeorona~ stent implantation on IRA at 7-10 daya
after symptom onset is safe, feasible and significantly reduce restenosis
rate.
11059-165I Stentingin Acute Myocardial lnfarction(STAMl):
Six Month Follow-up
K.H. Benzuly, W.W. O’Neill, V. Gangadharan, S.L. Almany, D. Maraalese,
S.C. Ajluni, F.V.Tilli, A.D. Berman, B. Haakins, R.D. Safian. Wihrr
Beaumont Hospital, ffoya/ Oak, M/, USA
Alter primary angioplasty (PTCA) for acute myocardial infarction, (AMI), tar-
get vessel revasculanzation (TVR) is required in 30-40% of patients. Elective
Palmaz-Schafz coronay stenting reduces restenoais, but the incidence of
restenosis following primary stenting forAMl is unknown. Between April 1995
and June 1996, 55 patients were enrolled in STAMI, a prospective pilot study
of planned primary stenting for AML There were 3 in-hospital deaths (4.2%,
including one patient with left ventricular free wall rupture). Clinical follow-up
for all surviving patients is shown in the table.
n (%)
FAJ(montha) 6*3
Chestpsin 17 (33)
Ml 2 (3,s)
PTCA (TVR) 6 (12)
CASG 2 (3,8)
TVR 2 (15)
Death 1(1.9)
/n conclusion: Patients treated with primary stenting for AMI have a low
incidence of clinical restenosis, need for TVR, and death, although recurrent
chest pain is common.
)1059-166]EleCtiveStenting in Acute MyOcardialhlfssrction:
Preliminary Reauita of the Florence Randomized
Electiva Stenting in Acute Coronary Occiuaion
(FRESCO) Study
D. Antoniucci, G.M. Santoro, L. Bolognese, R. Valenti, E. Taddeucci,
M. Trepani, P.F.Fazzini. r2ivisioir of Cardiology, Careggi Hospital, Florence,
Italy
Unplanned stenting aflerdirect PTCAisfeasible andasaociatad with favourable
clinical outcomes. However, it is still unknown if eleotive stenting may lower
restenosis and reoeclusion rates after successful direct PTCA. Since Jan-
uary 1996, 70 pts have bean randomized to “stent” (Group A) or ‘non-stent”
(Group B) affer successful direct PTCA(TIMI 3 and residual stenosis -=30%).
One-month and 6-month angiography was scheduled in all pfa. Stenting was
always attempted whatever the coronary anatomy, except for a reference
vessel diameter < 2.5 mm. Successful stent deployment rate was 100%.
One-month follow-up rate was 96%. Acute and l-month angiographic results
in Group A were significantly better than thoae in Group B:
Ref D bassline MLD post PTCA MLD 1 month
GroupA (n=35) 3.21 +0.46 3.35+0.49 3..26& 0.37
GroupB (n = 35) 3.06 + 0.40 2.94+ 0.37 2.94+ 0.56
p vslue 0.07<0.0001<0.0087
in-hoa@italrecurrent ischemia occurred in 1 pt of Group A (non fatal re-
AMI treatad with re-PTCA) and in 6 pts of Group B (rest angina treatad with
re-PTCA in 5; 2 deaths).
Corrclusions:prelimina~ results of this randomized study suggest a po-
tential benefit of elective stenting after successful direct PTCA on residual
stenosia and in-hospital recurrent ischemia.
